Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
DOXA.STthis companyDoxa AB	SEK 0.45	-1.69×	0.29×	8.91×	-39.96×	-393.1%	-249.4%	-175.9%	-528.3%	-17.0%	-2.8%	47.0%	0.69×	-27.88×	-1.81×	0.65×	0.0%	5	-0.16	2	C+
BACTI-B.STBactiguard Holding AB (publ)	SEK 15.55	-90.45×	2.21×	3.23×	18.08×	-178.3%	85.5%	-4.4%	-3.6%	-2.5%	-1.1%	-1.0%	0.52×	2.63×	-0.77×	1.67×	0.0%	8	0.28	2	C+
CANTA.STCantargia AB (publ)	SEK 1.55	7.08×	3.91×	3.28×	4.91×	1047.8%	99.0%	48.7%	46.4%	55.3%	57.9%	14.4%	0×	-1.83×	11.37×	9.8×	0.0%	5	3.27	4	A
CLBIO.STCorline Biomedical AB	SEK 12.80	-27.8×	4.33×	53.02×	-27.26×	-165.9%	-185.7%	-185.7%	-192.3%	-15.7%	-15.2%	-4.4%	0×	1.46×	0×	4.98×	0.0%	3	12.35	1	D+
ENZY.STEnzymatica AB (publ)	SEK 2.40	-9.05×	3.71×	8.56×	-9.17×	-287.0%	61.5%	-96.9%	-96.3%	-41.8%	-41.7%	-8.9%	0.01×	0.69×	-42.41×	3.65×	0.0%	4	10.82	1	C-
FLFLUO.STFluoGuide A/S	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Peer median	—	-18.42×	3.81×	5.92×	-2.13×	-172.1%	73.5%	-50.6%	-49.9%	-9.1%	-8.1%	-2.7%	0×	1.07×	-0.39×	4.32×	0.0%	5	7.05	2	—